Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat
The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modu...
Saved in:
Published in | Psychopharmacologia Vol. 176; no. 2; pp. 139 - 145 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Berlin
Springer
01.11.2004
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modulating prepulse inhibition (PPI) and latent inhibition (LI).
The effects of BLA D1 (SCH 23390) and D2/D3 (raclopride) receptor blockade on PPI and LI were examined.
Separate groups of male Long-Evans rats received bilateral intra-BLA infusions of SCH 23390 (3.2 or 6.4 microg/0.5 microl per side), raclopride (2.5 or 5.0 microg/0.5 microl per side) or saline prior to testing. In two experiments, the effects of BLA DA receptor antagonism on PPI of the acoustic startle response (ASR) and LI of conditioned taste aversion were determined. A control group received bilateral intra-striatal infusions of SCH 23390 or raclopride prior to PPI testing.
Intra-BLA SCH 23390 or raclopride had no effect on the ASR. Intra-BLA SCH 23390 enhanced and raclopride disrupted PPI, both in a dose-related manner. Intra-striatal SCH 23390 or raclopride had no effect on PPI or ASR magnitude. Finally, BLA DA receptor blockade had no effect on LI.
These results indicate that PPI is modulated by BLA DA and suggest that this modulation occurs independently of changes in NAc and/or mPFC DA transmission. They also suggest that BLA DA is not involved in modulating LI and add to evidence indicating that PPI and LI are mediated by different neural substrates. |
---|---|
AbstractList | Rationale: The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modulating prepulse inhibition (PPI) and latent inhibition (LI). Objective: The effects of BLA D sub(1) (SCH 23390) and D sub(2)/D sub(3) (raclopride) receptor blockade on PPI and LI were examined. Methods: Separate groups of male Long-Evans rats received bilateral intra-BLA infusions of SCH 23390 (3.2 or 6.4 mu g/0.5 mu l per side), raclopride (2.5 or 5.0 mu g/0.5 mu l per side) or saline prior to testing. In two experiments, the effects of BLA DA receptor antagonism on PPI of the acoustic startle response (ASR) and LI of conditioned taste aversion were determined. A control group received bilateral intra-striatal infusions of SCH 23390 or raclopride prior to PPI testing. Results: Intra-BLA SCH 23390 or raclopride had no effect on the ASR. Intra-BLA SCH 23390 enhanced and raclopride disrupted PPI, both in a dose-related manner. Intra-striatal SCH 23390 or raclopride had no effect on PPI or ASR magnitude. Finally, BLA DA receptor blockade had no effect on LI. Conclusions: These results indicate that PPI is modulated by BLA DA and suggest that this modulation occurs independently of changes in NAc and/or mPFC DA transmission. They also suggest that BLA DA is not involved in modulating LI and add to evidence indicating that PPI and LI are mediated by different neural substrates. The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modulating prepulse inhibition (PPI) and latent inhibition (LI). The effects of BLA D1 (SCH 23390) and D2/D3 (raclopride) receptor blockade on PPI and LI were examined. Separate groups of male Long-Evans rats received bilateral intra-BLA infusions of SCH 23390 (3.2 or 6.4 microg/0.5 microl per side), raclopride (2.5 or 5.0 microg/0.5 microl per side) or saline prior to testing. In two experiments, the effects of BLA DA receptor antagonism on PPI of the acoustic startle response (ASR) and LI of conditioned taste aversion were determined. A control group received bilateral intra-striatal infusions of SCH 23390 or raclopride prior to PPI testing. Intra-BLA SCH 23390 or raclopride had no effect on the ASR. Intra-BLA SCH 23390 enhanced and raclopride disrupted PPI, both in a dose-related manner. Intra-striatal SCH 23390 or raclopride had no effect on PPI or ASR magnitude. Finally, BLA DA receptor blockade had no effect on LI. These results indicate that PPI is modulated by BLA DA and suggest that this modulation occurs independently of changes in NAc and/or mPFC DA transmission. They also suggest that BLA DA is not involved in modulating LI and add to evidence indicating that PPI and LI are mediated by different neural substrates. The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modulating prepulse inhibition (PPI) and latent inhibition (LI). The effects of BLA D1 (SCH 23390) and D2/D3 (raclopride) receptor blockade on PPI and LI were examined. Separate groups of male Long-Evans rats received bilateral intra-BLA infusions of SCH 23390 (3.2 or 6.4 microg/0.5 microl per side), raclopride (2.5 or 5.0 microg/0.5 microl per side) or saline prior to testing. In two experiments, the effects of BLA DA receptor antagonism on PPI of the acoustic startle response (ASR) and LI of conditioned taste aversion were determined. A control group received bilateral intra-striatal infusions of SCH 23390 or raclopride prior to PPI testing. Intra-BLA SCH 23390 or raclopride had no effect on the ASR. Intra-BLA SCH 23390 enhanced and raclopride disrupted PPI, both in a dose-related manner. Intra-striatal SCH 23390 or raclopride had no effect on PPI or ASR magnitude. Finally, BLA DA receptor blockade had no effect on LI. These results indicate that PPI is modulated by BLA DA and suggest that this modulation occurs independently of changes in NAc and/or mPFC DA transmission. They also suggest that BLA DA is not involved in modulating LI and add to evidence indicating that PPI and LI are mediated by different neural substrates. RATIONALEThe dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the involvement of the BLA, and of NAc and mPFC DA, in select forms of information processing, we sought to determine the role of BLA DA in modulating prepulse inhibition (PPI) and latent inhibition (LI).OBJECTIVEThe effects of BLA D1 (SCH 23390) and D2/D3 (raclopride) receptor blockade on PPI and LI were examined.METHODSSeparate groups of male Long-Evans rats received bilateral intra-BLA infusions of SCH 23390 (3.2 or 6.4 microg/0.5 microl per side), raclopride (2.5 or 5.0 microg/0.5 microl per side) or saline prior to testing. In two experiments, the effects of BLA DA receptor antagonism on PPI of the acoustic startle response (ASR) and LI of conditioned taste aversion were determined. A control group received bilateral intra-striatal infusions of SCH 23390 or raclopride prior to PPI testing.RESULTSIntra-BLA SCH 23390 or raclopride had no effect on the ASR. Intra-BLA SCH 23390 enhanced and raclopride disrupted PPI, both in a dose-related manner. Intra-striatal SCH 23390 or raclopride had no effect on PPI or ASR magnitude. Finally, BLA DA receptor blockade had no effect on LI.CONCLUSIONSThese results indicate that PPI is modulated by BLA DA and suggest that this modulation occurs independently of changes in NAc and/or mPFC DA transmission. They also suggest that BLA DA is not involved in modulating LI and add to evidence indicating that PPI and LI are mediated by different neural substrates. |
Author | GRATTON, Alain STEVENSON, C. W |
Author_xml | – sequence: 1 givenname: C. W surname: STEVENSON fullname: STEVENSON, C. W organization: Douglas Hospital Research Centre, McGill University, 6875 Boulevard LaSalle, Montreal (Verdun), QC, H4H 1R3, Canada – sequence: 2 givenname: Alain surname: GRATTON fullname: GRATTON, Alain organization: Douglas Hospital Research Centre, McGill University, 6875 Boulevard LaSalle, Montreal (Verdun), QC, H4H 1R3, Canada |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16217207$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15114433$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU-L1jAQh4OsuO-ufgAvEgS9VTNJ2iRHWfwHC4LoOUzb6b5d2qQm7WG__aa8L6x4cS6B4fkNM3mu2EWIgRh7DeIDCGE-ZiEkqEoIXYE1rmqesQNoJSspjLxgByGUqhTU9pJd5XwvSmmrX7BLqAG0VurAjj_jRDwOvMUcJ1wp4cRxfrjrcULexwXnMRAfA59jvxVgDHd8SbRsU97bx7Ed1zEGjqHnez6sf3dLbj0ST7i-ZM8HLJlX5_ea_f7y-dfNt-r2x9fvN59uq07XsFbK9jVQNxA602oYbCtkK9F2BD2q3qHDjrRypm_lgDWRa8ygOmdJWUHUqGv2_jR3SfHPRnn185g7miYMFLfsGyNErZ39LwimKd_X1AV8-w94H7cUyhFegnUGpIMCwQnqUsw50eCXNM6YHjwIv8vyJ1m-KPC7LL-v-uY8eGtn6p8SZzsFeHcGMHc4DQlDN-YnrpFgimr1CHlTn4A |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1016_j_pbb_2005_08_018 crossref_primary_10_1007_s00213_015_3897_y crossref_primary_10_1007_s00213_013_3371_7 crossref_primary_10_1155_2012_591094 crossref_primary_10_1016_j_bbr_2021_113304 crossref_primary_10_1016_j_brainres_2012_11_049 crossref_primary_10_1016_j_bbr_2006_07_026 crossref_primary_10_1016_j_neuropharm_2006_08_016 crossref_primary_10_3390_brainsci13040697 crossref_primary_10_3390_brainsci14050502 crossref_primary_10_1016_j_bbr_2009_03_035 crossref_primary_10_3389_fnbeh_2015_00074 crossref_primary_10_2117_psysoc_2004_125 crossref_primary_10_1016_j_neulet_2006_03_060 crossref_primary_10_1016_j_neubiorev_2009_02_001 crossref_primary_10_1016_j_neulet_2011_10_055 crossref_primary_10_1016_j_bbr_2006_11_009 crossref_primary_10_1007_s00213_008_1072_4 crossref_primary_10_1007_s00221_018_5380_6 crossref_primary_10_1002_syn_20383 crossref_primary_10_1016_j_pbb_2007_03_014 crossref_primary_10_1016_j_bbr_2013_12_042 crossref_primary_10_1111_nyas_13369 crossref_primary_10_3724_SP_J_1042_2021_01030 crossref_primary_10_1007_s00213_005_0277_z crossref_primary_10_1016_j_physbeh_2009_12_006 crossref_primary_10_1101_lm_96605 crossref_primary_10_3389_fnbeh_2016_00148 crossref_primary_10_1007_s00213_011_2228_1 crossref_primary_10_1007_s11055_010_9285_5 crossref_primary_10_1016_j_neuroscience_2005_06_038 crossref_primary_10_1016_j_neuroscience_2006_06_059 crossref_primary_10_1007_s00213_015_4063_2 crossref_primary_10_1177_0269881110379282 |
Cites_doi | 10.1007/BF02245228 10.1016/S0361-9230(01)00592-5 10.1016/S0006-8993(98)00281-9 10.1016/0306-4522(96)00307-7 10.1016/0166-4328(96)00056-3 10.1016/S0306-4522(02)00553-5 10.1016/S0306-4522(00)00086-5 10.1037/0735-7044.117.1.136 10.1007/s00213-002-1313-x 10.1111/j.1749-6632.1999.tb09280.x 10.1016/0306-4522(91)90247-L 10.1046/j.1460-9568.2003.02560.x 10.1101/lm.33800 10.1007/BF02244616 10.1016/S0006-8993(99)01291-3 10.1111/j.1460-9568.1994.tb00576.x 10.1097/00008877-199304000-00011 10.1007/BF02245306 10.1523/JNEUROSCI.18-20-08394.1998 10.1037/0735-7044.102.2.195 10.1073/pnas.91.25.11771 10.1097/00008877-199603000-00002 10.1016/S0306-4522(00)00437-1 10.1007/s002130000369 10.1007/s002130050170 10.1016/0091-3057(88)90113-X 10.1016/0361-9230(90)90241-Q 10.1146/annurev.ne.15.030192.002033 10.1038/417282a 10.1007/s00213-003-1544-5 10.1007/BF02244063 10.1016/S0306-4522(96)00218-7 10.1093/oso/9780198505013.001.0001 10.1016/0006-8993(88)91136-5 10.1016/S0006-8993(01)02243-0 10.1016/S0091-3057(98)00079-3 10.1016/S0893-133X(96)00145-5 10.1016/0306-4522(93)90378-S 10.1037/0735-7044.114.3.647 10.1111/j.1460-9568.1997.tb01683.x 10.1007/s002130050342 10.1016/0091-3057(95)00160-X 10.1523/JNEUROSCI.22-01-00324.2002 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS Copyright Springer-Verlag 2004 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: Copyright Springer-Verlag 2004 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s00213-004-1879-6 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts ProQuest Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Chemoreception Abstracts ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Neurosciences Abstracts MEDLINE ProQuest One Psychology MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 145 |
ExternalDocumentID | 719726581 10_1007_s00213_004_1879_6 15114433 16217207 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS IQODW KOW N2Q R9- RHV SBY SOJ X7M ~EX CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
ID | FETCH-LOGICAL-c451t-38d51ecfea97b41f8b02b2a8ce1da3d9a9ace4397db2fa5ee967f3c98e380ee63 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 |
IngestDate | Sat Aug 17 03:45:29 EDT 2024 Fri Apr 12 09:06:48 EDT 2024 Thu Oct 10 18:51:16 EDT 2024 Fri Dec 06 03:30:19 EST 2024 Sat Sep 28 07:41:52 EDT 2024 Tue Sep 20 18:59:17 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Conditioned taste aversion Amygdala Rat Neuroleptic D3 Dopamine receptor SCH 23390 Acquisition process Acoustic startle response Gating Amygdaloid nucleus Raclopride Dopamine D1 receptor Dopamine antagonist Rodentia D1 Dopamine receptor Catecholamine D2/D3 receptor Sensorimotor gating Vertebrata Mammalia D2 Dopamine receptor Animal Neurotransmitter Perception Taste Conditioned aversion Latent inhibition Prepulse inhibition |
Language | English |
License | CC BY 4.0 http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-38d51ecfea97b41f8b02b2a8ce1da3d9a9ace4397db2fa5ee967f3c98e380ee63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 15114433 |
PQID | 218971291 |
PQPubID | 47309 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_67005498 proquest_miscellaneous_17603365 proquest_journals_218971291 crossref_primary_10_1007_s00213_004_1879_6 pubmed_primary_15114433 pascalfrancis_primary_16217207 |
PublicationCentury | 2000 |
PublicationDate | 2004-11-01 |
PublicationDateYYYYMMDD | 2004-11-01 |
PublicationDate_xml | – month: 11 year: 2004 text: 2004-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2004 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
References | 7704295 - Eur J Neurosci. 1994 Dec 1;6(12):1837-45 9135045 - Neuroscience. 1997 Feb;76(3):715-24 12015602 - Nature. 2002 May 16;417(6886):282-7 12535960 - Neuroscience. 2003;116(1):285-93 3365315 - Behav Neurosci. 1988 Apr;102(2):195-202, 324 9763482 - J Neurosci. 1998 Oct 15;18(20):8394-401 7862864 - Psychopharmacology (Berl). 1994 Jan;113(3-4):487-92 2292046 - Brain Res Bull. 1990 Sep;25(3):485-98 8981387 - Neuropsychopharmacology. 1997 Jan;16(1):42-50 9622611 - Brain Res. 1998 Jun 8;795(1-2):128-36 10415662 - Ann N Y Acad Sci. 1999 Jun 29;877:412-38 11224185 - Behav Pharmacol. 1993 Apr;4(2):183-186 3134111 - Brain Res. 1988 May 3;447(2):335-40 9517459 - Eur J Neurosci. 1997 Dec;9(12):2541-8 12601500 - Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97 11112798 - Learn Mem. 2000 Nov-Dec;7(6):393-9 9040116 - Psychopharmacology (Berl). 1997 Jan;129(2):112-20 10858611 - Neuroscience. 2000;98(1):55-60 9715813 - Pharmacol Biochem Behav. 1998 Sep;61(1):113-9 8587900 - Pharmacol Biochem Behav. 1995 Dec;52(4):649-54 12670317 - Eur J Neurosci. 2003 Mar;17(6):1287-95 7991534 - Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11771-6 1575447 - Annu Rev Neurosci. 1992;15:353-75 8515846 - Neuroscience. 1993 May;54(1):5-9 12898122 - Psychopharmacology (Berl). 2003 Nov;170(3):263-70 1722886 - Neuroscience. 1991;44(1):1-14 3227035 - Pharmacol Biochem Behav. 1988 Aug;30(4):871-8 11224403 - Behav Pharmacol. 1996 Mar;7(2):119-129 2315438 - Psychopharmacology (Berl). 1990;100(3):413-6 12619916 - Behav Neurosci. 2003 Feb;117(1):136-43 9292624 - Psychopharmacology (Berl). 1997 Aug;132(3):247-54 1410139 - Psychopharmacology (Berl). 1992;108(1-2):189-95 11113341 - Neuroscience. 2000;101(4):921-30 10320690 - Brain Res. 1999 May 8;827(1-2):28-40 8788859 - Behav Brain Res. 1995 Dec 14;72(1-2):73-81 10883814 - Behav Neurosci. 2000 Jun;114(3):647-51 11756516 - J Neurosci. 2002 Jan 1;22(1):324-37 11311883 - Brain Res. 2001 Apr 27;899(1-2):218-26 8931016 - Neuroscience. 1996 Nov;75(2):535-42 11604248 - Brain Res Bull. 2001 Sep 1;56(1):49-53 10805614 - Psychopharmacology (Berl). 2000 Apr;149(2):181-8 2114026 - Psychopharmacology (Berl). 1990;101(3):414-20 Rosen (CR26) 1988; 102 Coutureau (CR4) 2001; 56 Stevenson (CR34) 2003; 161 Weiner (CR44) 1997; 16 Guarraci (CR14) 2000; 114 Warburton (CR40) 1996; 7 Russig (CR29) 2003; 170 Zhang (CR46) 2000; 149 McDonald (CR24) 1991; 44 Fendt (CR9) 2000; 98 Peters (CR25) 1993; 4 Swerdlow (CR36) 1990; 100 Ellenbroek (CR6) 1996; 75 Ellenbroek (CR7) 1997; 129 Geyer (CR11) 1990; 25 Schauz (CR30) 2000; 7 Swerdlow (CR35) 1990; 101 Greba (CR12) 2001; 899 CR1 Weiner (CR42) 2003; 169 Gallagher (CR10) 1994; 91 Shoemaker (CR31) 2003; 117 Simon (CR32) 1988; 447 Joseph (CR20) 2000; 101 Rosenkranz (CR27) 2002; 417 Lamont (CR22) 1998; 795 Swerdlow (CR37) 1992; 108 CR23 Bubser (CR3) 1994; 113 Stevenson (CR33) 2003; 17 Koch (CR21) 1994; 6 Weiner (CR41) 1988; 30 Wan (CR39) 1997; 76 Davis (CR5) 1992; 15 Harmer (CR15) 1997; 132 Bakshi (CR2) 1998; 18 Rosenkranz (CR28) 2002; 22 Guarraci (CR13) 1999; 827 Hurd (CR18) 1997; 9 Everitt (CR8) 1999; 877 Weiner (CR43) 1996; 72 Johansson (CR19) 1995; 52 Hart (CR16) 1998; 61 Young (CR45) 1993; 54 |
References_xml | – volume: 113 start-page: 487 year: 1994 ident: CR3 publication-title: Psychopharmacology doi: 10.1007/BF02245228 contributor: fullname: Bubser – volume: 56 start-page: 49 year: 2001 ident: CR4 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(01)00592-5 contributor: fullname: Coutureau – volume: 795 start-page: 128 year: 1998 ident: CR22 publication-title: Brain Res doi: 10.1016/S0006-8993(98)00281-9 contributor: fullname: Lamont – volume: 75 start-page: 535 year: 1996 ident: CR6 publication-title: Neuroscience doi: 10.1016/0306-4522(96)00307-7 contributor: fullname: Ellenbroek – volume: 72 start-page: 73 year: 1996 ident: CR43 publication-title: Behav Brain Res doi: 10.1016/0166-4328(96)00056-3 contributor: fullname: Weiner – volume: 161 start-page: 285 year: 2003 ident: CR34 publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00553-5 contributor: fullname: Stevenson – volume: 98 start-page: 55 year: 2000 ident: CR9 publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00086-5 contributor: fullname: Fendt – volume: 117 start-page: 136 year: 2003 ident: CR31 publication-title: Behav Neurosci doi: 10.1037/0735-7044.117.1.136 contributor: fullname: Shoemaker – volume: 169 start-page: 257 year: 2003 ident: CR42 publication-title: Psychopharmacology doi: 10.1007/s00213-002-1313-x contributor: fullname: Weiner – volume: 877 start-page: 412 year: 1999 ident: CR8 publication-title: Ann NY Acad Sci doi: 10.1111/j.1749-6632.1999.tb09280.x contributor: fullname: Everitt – volume: 44 start-page: 1 year: 1991 ident: CR24 publication-title: Neuroscience doi: 10.1016/0306-4522(91)90247-L contributor: fullname: McDonald – volume: 17 start-page: 1287 year: 2003 ident: CR33 publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2003.02560.x contributor: fullname: Stevenson – volume: 7 start-page: 393 year: 2000 ident: CR30 publication-title: Learn Mem doi: 10.1101/lm.33800 contributor: fullname: Schauz – volume: 100 start-page: 413 year: 1990 ident: CR36 publication-title: Psychopharmacology doi: 10.1007/BF02244616 contributor: fullname: Swerdlow – volume: 827 start-page: 28 year: 1999 ident: CR13 publication-title: Brain Res doi: 10.1016/S0006-8993(99)01291-3 contributor: fullname: Guarraci – volume: 6 start-page: 1837 year: 1994 ident: CR21 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.1994.tb00576.x contributor: fullname: Koch – volume: 4 start-page: 183 year: 1993 ident: CR25 publication-title: Behav Pharmacol doi: 10.1097/00008877-199304000-00011 contributor: fullname: Peters – volume: 108 start-page: 189 year: 1992 ident: CR37 publication-title: Psychopharmacology doi: 10.1007/BF02245306 contributor: fullname: Swerdlow – volume: 18 start-page: 8394 year: 1998 ident: CR2 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-20-08394.1998 contributor: fullname: Bakshi – volume: 102 start-page: 195 year: 1988 ident: CR26 publication-title: Behav Neurosci doi: 10.1037/0735-7044.102.2.195 contributor: fullname: Rosen – volume: 91 start-page: 11771 year: 1994 ident: CR10 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.91.25.11771 contributor: fullname: Gallagher – volume: 7 start-page: 119 year: 1996 ident: CR40 publication-title: Behav Pharmacol doi: 10.1097/00008877-199603000-00002 contributor: fullname: Warburton – volume: 101 start-page: 921 year: 2000 ident: CR20 publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00437-1 contributor: fullname: Joseph – volume: 149 start-page: 181 year: 2000 ident: CR46 publication-title: Psychopharmacology doi: 10.1007/s002130000369 contributor: fullname: Zhang – volume: 129 start-page: 112 year: 1997 ident: CR7 publication-title: Psychopharmacology doi: 10.1007/s002130050170 contributor: fullname: Ellenbroek – ident: CR23 – volume: 30 start-page: 871 year: 1988 ident: CR41 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(88)90113-X contributor: fullname: Weiner – volume: 25 start-page: 485 year: 1990 ident: CR11 publication-title: Brain Res Bull doi: 10.1016/0361-9230(90)90241-Q contributor: fullname: Geyer – volume: 15 start-page: 353 year: 1992 ident: CR5 publication-title: Ann Rev Neurosci doi: 10.1146/annurev.ne.15.030192.002033 contributor: fullname: Davis – volume: 417 start-page: 282 year: 2002 ident: CR27 publication-title: Nature doi: 10.1038/417282a contributor: fullname: Rosenkranz – volume: 170 start-page: 263 year: 2003 ident: CR29 publication-title: Psychopharmacology doi: 10.1007/s00213-003-1544-5 contributor: fullname: Russig – volume: 101 start-page: 414 year: 1990 ident: CR35 publication-title: Psychopharmacology doi: 10.1007/BF02244063 contributor: fullname: Swerdlow – volume: 76 start-page: 715 year: 1997 ident: CR39 publication-title: Neuroscience doi: 10.1016/S0306-4522(96)00218-7 contributor: fullname: Wan – ident: CR1 doi: 10.1093/oso/9780198505013.001.0001 – volume: 447 start-page: 335 year: 1988 ident: CR32 publication-title: Brain Res doi: 10.1016/0006-8993(88)91136-5 contributor: fullname: Simon – volume: 899 start-page: 218 year: 2001 ident: CR12 publication-title: Brain Res doi: 10.1016/S0006-8993(01)02243-0 contributor: fullname: Greba – volume: 61 start-page: 113 year: 1998 ident: CR16 publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(98)00079-3 contributor: fullname: Hart – volume: 16 start-page: 42 year: 1997 ident: CR44 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00145-5 contributor: fullname: Weiner – volume: 54 start-page: 5 year: 1993 ident: CR45 publication-title: Neuroscience doi: 10.1016/0306-4522(93)90378-S contributor: fullname: Young – volume: 114 start-page: 647 year: 2000 ident: CR14 publication-title: Behav Neurosci doi: 10.1037/0735-7044.114.3.647 contributor: fullname: Guarraci – volume: 9 start-page: 2541 year: 1997 ident: CR18 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.1997.tb01683.x contributor: fullname: Hurd – volume: 132 start-page: 247 year: 1997 ident: CR15 publication-title: Psychopharmacology doi: 10.1007/s002130050342 contributor: fullname: Harmer – volume: 52 start-page: 649 year: 1995 ident: CR19 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(95)00160-X contributor: fullname: Johansson – volume: 22 start-page: 324 year: 2002 ident: CR28 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-01-00324.2002 contributor: fullname: Rosenkranz |
SSID | ssj0000484 ssj0068394 |
Score | 1.9985805 |
Snippet | The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission. Given the... Rationale: The dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA... RATIONALEThe dopamine (DA) projection to the basolateral amygdala (BLA) modulates nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) DA transmission.... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 139 |
SubjectTerms | Amygdala - drug effects Amygdala - physiology Animals Biological and medical sciences Dopamine - physiology Dopamine Antagonists - pharmacology Dose-Response Relationship, Drug Male Medical sciences Neural Inhibition - drug effects Neural Inhibition - physiology Neuropharmacology Pharmacology. Drug treatments Rats Rats, Long-Evans Receptors, Dopamine - physiology Reflex, Startle - drug effects Reflex, Startle - physiology |
Title | Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15114433 https://www.proquest.com/docview/218971291 https://search.proquest.com/docview/17603365 https://search.proquest.com/docview/67005498 |
Volume | 176 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0BRFEtGqN1XMfpA_SYJL9yOZJVFqK0HKUFu4t7GdbuEvS5u7h_vvOJrmLfaiP2WSysDO789udnd8AfLPSKCOMj13Gfcy0wSmlBY851TZlKKNpyEY-OxenV-zvjM-GuzntcK1ysyZ2C7WtTTgj_4GuqMjROaU_m7s4FI0KwdWhgsZz2E0z9ORozvksHxdiFnIw-weBQKBnZKYhn4zLTYQz6QhFs1DjIDD4ybyIxSMf9apRLQ6X7-tcPA1EO4d08gZeD0iS_OpV_xaeuWoPXpwNsfI9OJz2rNTrI3I5Jlm1R-SQTEe-6vU7uLmo547UnqBHw41uSEmeE7VYX1s1V8TirnqBPyS3FVnUtqv2VV2T5t41K3Sr2Hxzq7t7X0RVlgT5avlvK8ohyCRoae_h6uT48s9pPBRgiA3j6TKm0vLUGe9UkWuWeqmTTGdKGpdaRW2hCmVcQDRWZ15x5wqRe2oK6ahMnBP0A-xUdeU-AgkhHcVCmq23TCRMZbj1RPigTEdBzyL4vhnysul5Nsoto3KnnxL1Uwb9lCKCySOljBIi1NtK8ggONloqhznZllsLiuDr9i1OphAhUZWrV22Z5gLtQ_CnvwhZTbillhHs98of-0boyhiln_7b9wG87KkiwyHOZ9hZ3q_cF4Q1Sz3pjHcCu7-Pz6cXD2EC9zc |
link.rule.ids | 314,780,784,12056,21388,27924,27925,31719,31720,33744,33745,43310,43805,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJwHShGB8hcHmB7QHtGhNYjvJEwK0qcBaVVMn7S3yV7ZJbZIt7UP_e-6StGEP4zFOLpZ8Z9_PPt_vAL7YxCgjTe67UOQ-1wanlJbCF5G2AUcZHVE28ngiR5f895W46u7m1N21ys2a2CzUtjR0Rn6CriiN0TkF36o7n4pGUXC1q6DxFHaIOF0MYOfH6WR60S_FnLIw2weJUKDlZI4oo0wkmxjnsKEUDanKAXH4JXHqywdeardSNQ5Y3la6eByKNi7p7BW87LAk-94q_zU8ccUePBt30fI9OJq2vNTrYzbr06zqY3bEpj1j9foN3FyUc8fKnKFPw60uJSXPmVqsr62aK2ZxX73AH7Lbgi1K29T7Kq5Zde-qFTpWbL651c3NL6YKy0i-WP7binIIMxna2lu4PDud_Rz5XQkG33ARLP0osSJwJncqjTUP8kQPQx2qxLjAqsimKlXGEaaxOsyVcC6VcR6ZNHGoD-dk9A4GRVm4D8AoqKM4JdrmlsshVyFuPhFAKNOQ0HMPvm6GPKtapo1sy6nc6CdD_WSkn0x6cPBAKb2EpIpbw9iD_Y2Wsm5W1tnWhjw43L7F6UQxElW4clVnQSzRPqR4_AvKa8JNdeLB-1b5fd8IXjmPoo__7fsQno9m4_Ps_Nfkzz68aIkj6UjnEwyW9yv3GUHOUh90pvwXmJf58w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB61i4QqVailr0ALPlQcKiKS-JHkVPXBij5YrRBI3CI_AWk3ScnuYf99x0l2Uw70GCcTS56x57PH8w3AR5NpqYV2oU24C5nSOKWU4CGnysQMZRT12cjnE3F2xX5e8-ueUqjpr1Wu18R2oTaV9mfkJ-iK8hSdU3zi-lsR0-_jz_Wf0BeQ8oHWvprGU9hCpxglI9j6ejqZXgzLMvMZmd2DQFjQ8TNTn13Gs3W8M2rpRRNf8cDz-WVpHooHHut5LRscPNdVvXgclrbuafwCdnpcSb50hvASnthyF7bP-8j5LhxNO47q1TG5HFKummNyRKYDe_XqFdxeVDNLKkfQv-G21ycoz4icr26MnElicI89xx-Su5LMK9PW_ipvSH1v6yU6WWy-vVPtLTAiS0O8fLn4txXlEHIStLvXcDU-vfx2FvblGELNeLwIaWZ4bLWzMk8Vi12mokQlMtM2NpKaXOZSW49vjEqc5NbmInVU55mlWWStoG9gVFalfQfEB3gk80m3zjARMZngRhTBhNQtIT0L4NN6yIu6Y90oNvzKrX4K1E_h9VOIAA4eKGWQEL76VpQGsL_WUtHP0KbY2FMAh5u3OLV8vESWtlo2RZwKtA_BH__C5zjhBjsL4G2n_KFvBLKMUbr3374PYRutuPj9Y_JrH551HJL-dOc9jBb3S_sB8c5CHfSW_BdS3_4g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+basolateral+amygdala+dopamine+in+modulating+prepulse+inhibition+and+latent+inhibition+in+the+rat&rft.jtitle=Psychopharmacology&rft.au=Stevenson%2C+C.+W.&rft.au=Gratton%2C+Alain&rft.date=2004-11-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=176&rft.issue=2&rft.spage=139&rft.epage=145&rft_id=info:doi/10.1007%2Fs00213-004-1879-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00213_004_1879_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |